Akira Hashiramoto Selected Research

Akira Hashiramoto Research Topics

Disease

22	Rheumatoid Arthritis 08/2021 - 01/2005
4	Arthritis (Polyarthritis) 07/2020 - 08/2002
2	Autoimmune Diseases (Autoimmune Disease) 03/2020 - 07/2013
2	Glomerulonephritis 01/2019 - 07/2013
2	Infections 08/2012 - 07/2011
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2011 - 09/2004
2	Osteoporosis 05/2005 - 04/2005
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021
1	Vasculitis (Vasculitides) 01/2021
1	Thromboinflammation 01/2021
1	Experimental Arthritis 07/2020
1	Alopecia (Baldness) 01/2019
1	Leukemia 01/2018
1	Rheumatic Diseases (Rheumatism) 06/2017
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2009
1	Disease Susceptibility (Diathesis) 08/2008
1	Osteoarthritis 03/2006
1	Ascites 09/2004
1	Central Nervous System Lupus Vasculitis 09/2004
1	Peritonitis 09/2004
1	Psychotic Disorders (Schizoaffective Disorder) 09/2004
1	Type 2 Diabetes Mellitus (MODY) 03/2003
1	Insulin Resistance 03/2003
1	Osteopetrosis 06/2002

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 07/2020 - 07/2008
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 07/2008
4	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 01/2005
3	Cell-Free Nucleic AcidsIBA 08/2021 - 06/2017
2	LigandsIBA 07/2020 - 05/2005
2	OsteoprotegerinIBA 07/2020 - 05/2005
2	AutoantibodiesIBA 01/2019 - 07/2013
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2019 - 07/2013
2	Member 25 Tumor Necrosis Factor ReceptorsIBA 01/2018 - 03/2006
2	Biological ProductsIBA 06/2017 - 11/2012
2	tocilizumab (atlizumab)FDA Link 11/2013 - 11/2012
2	Pharmaceutical PreparationsIBA 11/2012 - 01/2005
2	Tumor Necrosis Factor InhibitorsIBA 08/2012 - 07/2011
2	Antirheumatic Agents (DMARD)IBA 06/2012 - 07/2011
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 07/2008 - 04/2005
2	DNA (Deoxyribonucleic Acid)IBA 03/2006 - 04/2005
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021
1	Deoxyribonucleases (DNase)FDA Link 01/2021
1	AlbuminsIBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Etanercept (Enbrel)FDA Link 11/2012
1	Infliximab (Remicade)FDA Link 11/2012
1	Adalimumab (Humira)FDA Link 06/2012
1	Peptides (Polypeptides)IBA 10/2011
1	Alanine (L-Alanine)FDA Link 10/2011
1	micaIBA 10/2011
1	CryptochromesIBA 02/2010
1	Phosphotransferases (Kinase)IBA 02/2010
1	Interleukin-6 (Interleukin 6)IBA 02/2010
1	cevimeline (Evoxac)FDA Link 01/2009
1	Collagen Type II (Type II Collagen)IBA 07/2008
1	Interleukin-1beta (Interleukin 1 beta)IBA 07/2008
1	Matrix Metalloproteinases (MMPs)IBA 07/2008
1	C-Reactive ProteinIBA 03/2008
1	cyclic citrullinated peptideIBA 03/2008
1	Rheumatoid FactorIBA 03/2008
1	Angiopoietin-1IBA 07/2007
1	Proteins (Proteins, Gene)FDA Link 03/2006
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 05/2005
1	Estrogens (Estrogen)FDA Link 05/2005
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2005
1	Capsules (Microcapsules)IBA 01/2005
1	Methylprednisolone FDA LinkGeneric 09/2004
1	SteroidsIBA 09/2004
1	DiureticsIBA 09/2004
1	G(M3) GangliosideIBA 03/2003
1	Insulin ReceptorIBA 03/2003
1	Insulin (Novolin)FDA Link 03/2003
1	pristane (pristan)IBA 08/2002
1	Macrophage Colony-Stimulating FactorIBA 06/2002
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2002

Therapy/Procedure

5	Therapeutics 11/2013 - 09/2004
1	Chronotherapy 07/2020
1	Biological Therapy 11/2012